Nano-X Imaging Ltd NNOX

Annual Quarterly

FY2025 · ended Dec 31, 2025 · Revenue $13.02M, +15.4% YoY · Filed Apr 30, 2026

Nano-X Imaging Ltd (NNOX) files with the SEC under industry code 3844, X-Ray Apparatus & Tubes & Related Irradiation Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $13.0 million and a net loss of $75.0 million. Free cash flow was -$45.0 million. As of Dec 31, 2025 it held $49.2 million in cash and investments and $7.9 million in total debt.

Revenue
$13.02M
+15.4% vs prior year
Net income
$-75.02M
-40.2% vs prior year
Operating cash flow
$-40.79M
-11.5% vs prior year
Free cash flow
$-45.00M
-14.3% vs prior year
EPS
$-1.16
-27.5% vs prior year
Dividend per share
None
Shares outstanding
69.59M
+9.1% vs prior year
Net cash
$41.30M
FY 2025
Operating margin
-600.8%
FY 2025

Company profile

Industry
X-Ray Apparatus & Tubes & Related Irradiation Apparatus (SIC 3844)
Listed as
NNOX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Israel
Headquarters
Petach Tikva, Israel
SEC filer status
Accelerated filer
SEC CIK
1795251

Other X-Ray Apparatus & Tubes & Related Irradiation Apparatus companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
$13.0M
$11.3M
$9.9M
$8.6M
$1.3M
Operating income
-$78.2M
-$56.7M
-$62.6M
-$117.7M
-$61.6M
Net income
-$75.0M
-$53.5M
-$60.8M
-$113.2M
-$61.8M
Diluted EPS
-$1.16
-$0.91
-$1.08
-$2.17
—
Operating cash flow
-$40.8M
-$36.6M
-$44.8M
-$43.4M
-$38.1M
Free cash flow
-$45.0M
-$39.4M
-$48.1M
-$50.6M
-$61.2M
Total assets
$162.2M
$210.0M
$218.6M
$253.9M
$363.2M
Total liabilities
$22.4M
$20.9M
$23.1M
$37.3M
$71.0M
Stockholders' equity
$139.7M
$189.1M
$195.5M
$216.7M
$292.1M
Cash and investments
$49.2M
$57.7M
$82.4M
$102.8M
$156.6M
Total debt
$7.9M
$7.4M
$8.4M
$13.0M
$50.3M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
6-K Current report (foreign issuer) Oct 28, 2026 Oct 28, 2026
6-K Current report (foreign issuer) Oct 28, 2026 Oct 28, 2026
6-K Current report (foreign issuer) Oct 16, 2026 Oct 16, 2026
6-K Current report (foreign issuer) Oct 2, 2026 Oct 2, 2026
6-K Current report (foreign issuer) Sep 29, 2026 Sep 29, 2026
6-K Current report (foreign issuer) Sep 17, 2026 Sep 17, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.